BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35902747)

  • 1. rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis.
    Zhang H; Nagree MS; Liu H; Pan X; Medin JA; Lipinski DM
    Gene Ther; 2023 Apr; 30(3-4):297-308. PubMed ID: 35902747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment.
    Yu FPS; Sajdak BS; Sikora J; Salmon AE; Nagree MS; Gurka J; Kassem IS; Lipinski DM; Carroll J; Medin JA
    Am J Pathol; 2019 Feb; 189(2):320-338. PubMed ID: 30472209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic ceramide accumulation leads to severe and varied pathological consequences.
    Alayoubi AM; Wang JC; Au BC; Carpentier S; Garcia V; Dworski S; El-Ghamrasni S; Kirouac KN; Exertier MJ; Xiong ZJ; Privé GG; Simonaro CM; Casas J; Fabrias G; Schuchman EH; Turner PV; Hakem R; Levade T; Medin JA
    EMBO Mol Med; 2013 Jun; 5(6):827-42. PubMed ID: 23681708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency.
    Yu FPS; Islam D; Sikora J; Dworski S; Gurka J; López-Vásquez L; Liu M; Kuebler WM; Levade T; Zhang H; Medin JA
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L406-L420. PubMed ID: 29167126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene.
    Alves MQ; Le Trionnaire E; Ribeiro I; Carpentier S; Harzer K; Levade T; Ribeiro MG
    Mol Genet Metab; 2013 Jul; 109(3):276-81. PubMed ID: 23707712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency.
    Nagree MS; Rybova J; Kleynerman A; Ahrenhoerster CJ; Saville JT; Xu T; Bachochin M; McKillop WM; Lawlor MW; Pshezhetsky AV; Isaeva O; Budde MD; Fuller M; Medin JA
    Commun Biol; 2023 May; 6(1):560. PubMed ID: 37231125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analyses of novel ASAH1 mutations causing Farber lipogranulomatosis: analyses of exonic splicing enhancer inactivating mutation.
    Bashyam MD; Chaudhary AK; Kiran M; Reddy V; Nagarajaram HA; Dalal A; Bashyam L; Suri D; Gupta A; Gupta N; Kabra M; Puri RD; RamaDevi R; Kapoor S; Danda S
    Clin Genet; 2014 Dec; 86(6):530-8. PubMed ID: 24355074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content.
    Kyriakou K; Lederer CW; Kleanthous M; Drousiotou A; Malekkou A
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions.
    Kleynerman A; Rybova J; Faber ML; McKillop WM; Levade T; Medin JA
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy.
    Elsea SH; Solyom A; Martin K; Harmatz P; Mitchell J; Lampe C; Grant C; Selim L; Mungan NO; Guelbert N; Magnusson B; Sundberg E; Puri R; Kapoor S; Arslan N; DiRocco M; Zaki M; Ozen S; Mahmoud IG; Ehlert K; Hahn A; Gokcay G; Torcoletti M; Ferreira CR
    Hum Mutat; 2020 Sep; 41(9):1469-1487. PubMed ID: 32449975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic pathology and altered gene transcription in a murine model of acid ceramidase deficiency.
    Yu FPS; Molino S; Sikora J; Rasmussen S; Rybova J; Tate E; Geurts AM; Turner PV; Mckillop WM; Medin JA
    Lab Invest; 2019 Oct; 99(10):1572-1592. PubMed ID: 31186526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid ceramidase deficiency: Farber disease and SMA-PME.
    Yu FPS; Amintas S; Levade T; Medin JA
    Orphanet J Rare Dis; 2018 Jul; 13(1):121. PubMed ID: 30029679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farber disease in a patient from China.
    Bao X; Ma M; Zhang Z; Xu Y; Qiu Z
    Am J Med Genet A; 2020 Sep; 182(9):2184-2186. PubMed ID: 32706452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1.
    Brooks BM; Yeh CD; Beers J; Liu C; Cheng YS; Gorshkov K; Zou J; Zheng W; Chen CZ
    Stem Cell Res; 2021 May; 53():102387. PubMed ID: 34088014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the activation of acid ceramidase.
    Gebai A; Gorelik A; Li Z; Illes K; Nagar B
    Nat Commun; 2018 Apr; 9(1):1621. PubMed ID: 29692406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hematopoietic cell transplantation in Farber disease.
    Ehlert K; Levade T; Di Rocco M; Lanino E; Albert MH; Führer M; Jarisch A; Güngör T; Ayuk F; Vormoor J
    J Inherit Metab Dis; 2019 Mar; 42(2):286-294. PubMed ID: 30815900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical presentation of infantile-onset farber disease with novel ASAH1 mutations.
    Kim SY; Choi SA; Lee S; Lee JS; Hong CR; Lim BC; Kang HJ; Kim KJ; Park SH; Choi M; Chae JH
    Am J Med Genet A; 2016 Nov; 170(11):3023-3027. PubMed ID: 27411168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities.
    Sikora J; Dworski S; Jones EE; Kamani MA; Micsenyi MC; Sawada T; Le Faouder P; Bertrand-Michel J; Dupuy A; Dunn CK; Xuan ICY; Casas J; Fabrias G; Hampson DR; Levade T; Drake RR; Medin JA; Walkley SU
    Am J Pathol; 2017 Apr; 187(4):864-883. PubMed ID: 28342444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease.
    Ramsubir S; Nonaka T; Girbés CB; Carpentier S; Levade T; Medin JA
    Mol Genet Metab; 2008 Nov; 95(3):133-41. PubMed ID: 18805722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple fluorogenic method for determination of acid ceramidase activity and diagnosis of Farber disease.
    Bedia C; Camacho L; Abad JL; Fabriàs G; Levade T
    J Lipid Res; 2010 Dec; 51(12):3542-7. PubMed ID: 20871013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.